CSIMarket Company Name, Ticker, Industry, else..
 
Bausch Health Companies Inc   (NYSE: BHC)
 
Price: $6.7600 $-0.07 -1.025%
Day's High: $6.989999771118164 Week Perf: 6.96 %
Day's Low: $ 6.62 30 Day Perf: 7.47 %
Volume (M): 2,059,699 52 Wk High: $ 8.00
Volume (M$): $ 0 52 Wk Avg: $6.01
Open: $6.91 52 Wk Low: $4.33



 Market Capitalization (Millions $) 2,520
 Shares Outstanding (Millions) 373
 Employees 20,300
 Revenues (TTM) (Millions $) 10,531
 Net Income (TTM) (Millions $) -1,225
 Cash Flow (TTM) (Millions $) 155
 Capital Exp. (TTM) (Millions $) 669

Business Description


Bausch Health Companies Inc. (formerly known as Valeant Pharmaceuticals International Inc.) is a multinational pharmaceutical company that was founded in 1960 and is based in Laval, Canada. The company focuses on innovative pharmaceutical products and medical devices for the treatment of eye health, gastroenterology, dermatology, and aesthetics. Bausch Health operates in more than 100 countries, selling products to healthcare providers and patients around the world.

Bausch Health has a diverse portfolio of products, including prescription drugs, over-the-counter medications, contact lenses, surgical instruments, and biologic drugs. The company has a number of strong brands, including Bausch + Lomb, Salix Pharmaceuticals, and Ortho Dermatologics. Bausch + Lomb is a leading global eye health business that offers contact lenses, ocular drugs, and surgical instruments. Salix Pharmaceuticals is a specialized gastroenterology company that offers treatments for gastrointestinal diseases. Ortho Dermatologics offers prescription dermatology products.

Bausch Health is committed to research and development, spending significant resources on developing new products and improving existing ones. The company has a strong pipeline of products, and it invests heavily in clinical trials to ensure that its products are effective and safe.

Bausch Health has faced regulatory and legal challenges in the past, including allegations of accounting fraud and price gouging for some of its drugs. In response, the company has implemented a number of reforms, including changes to its governance structure and pricing policies.

Overall, Bausch Health Companies Inc. is a major player in the pharmaceutical industry, with a diverse portfolio of products and a strong commitment to research and development. The company has faced challenges in the past but has taken steps to improve its reputation and ensure that its products are accessible and affordable for patients.


   Company Address: 2150 St. Elzéar Blvd. West Laval 0 QC
   Company Phone Number: 744-6792   Stock Exchange / Ticker: NYSE BHC


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
ABBV        0.8% 
BMY        1.7% 
JNJ        4.76% 
LLY   -1.4%    
MRK        1.87% 
PFE        2.82% 
• View Complete Report
   



Stocks on the Move

Bausch Healths Ongoing Struggles A Cautionary Tale of Debt and Market Sentiment

Published Fri, Jul 26 2024 7:20 PM UTC

The recent performance of Bausch Health Companies Inc., which has lagged behind the broader market by nearly 17.89% so far this year, reflects a multitude of factors, from financial instability to persistent rumors of bankruptcy. After suffering a staggering decline of over 40% in stock value amidst swirling speculation regarding its financial health, Bausch Health s managem...



Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.24
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.67
Working Capital Ratio 1.64
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) 1.46
Debt Coverage (TTM) 0.12

Per Share Current
Earnings (TTM) -3.24 $
Revenues (TTM) 28.25 $
Cash Flow (TTM) 0.42 $
Cash 3.48 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 518,768
Net Income per Employee (TTM) -60,345
Receivable Turnover Ratio (TTM) 345.28
Inventory Turnover Ratio (TTM) 3.07
Asset Turnover Ratio (TTM) 0.23

Profitability Ratios Current
Gross Margin (MRQ) 71.43 %
Operating Margin (MRQ) -37.64 %
Net Margin (MRQ) -56.7 %
Net Cash Flow Margin (MRQ) -0.52 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -



Bausch Health Companies Inc's Segments
Product sales    99.05 % of total Revenue
Other revenues    0.95 % of total Revenue
Segment    100 % of total Revenue
Salix    25.32 % of total Revenue
Salix Product sales    1.86 % of total Revenue
International    11.29 % of total Revenue
International Product sales    4.44 % of total Revenue
International Other revenues    0.63 % of total Revenue
Solta Medical    6.77 % of total Revenue
Solta Medical Product sales    2.1 % of total Revenue
Diversified    7.33 % of total Revenue
Diversified Product sales    1.07 % of total Revenue
Bausch Lomb    49.29 % of total Revenue
Bausch Lomb Product sales    19.1 % of total Revenue
Bausch Lomb Other revenues    0.04 % of total Revenue





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.